rd4sndk

The Pfizer-Wyeth Deal: Experimenting with Taxpayer Dollars?

Its this type of blog that's driving me crazy. Do you expect Pfizer to welch on its loans or that the expected $20B in CF to not materialize? How obsurb is to restrict the banks from loaning to a bluechip company with $20B+ in cash reserves and a FCF greater than $10B. Find something else to do with your time and leave us alone with absurb fears of Pfizer failures. I for one welcome such transactions and plan to take part in the arbitrage shortfall to reap my 12% in 90 days.

There are transactions that unhealthy banks have made and I didn't hear you questioning those like Citi's planned purchase of Wachovia etc. Now there's a merger that was rightfully terminated.